Cullinan Therapeutics Inc (CGEM)
15.30
-0.49
(-3.10%)
USD |
NASDAQ |
Nov 14, 16:00
15.31
+0.01
(+0.07%)
After-Hours: 16:41
Cullinan Therapeutics Total Liabilities (Quarterly): 25.00M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 25.00M |
| March 31, 2024 | 23.76M |
| December 31, 2023 | 30.29M |
| September 30, 2023 | 25.89M |
| June 30, 2023 | 22.41M |
| March 31, 2023 | 29.34M |
| December 31, 2022 | 26.09M |
| September 30, 2022 | 31.11M |
| June 30, 2022 | 62.63M |
| Date | Value |
|---|---|
| March 31, 2022 | 17.99M |
| December 31, 2021 | 11.81M |
| September 30, 2021 | 7.93M |
| June 30, 2021 | 5.813M |
| March 31, 2021 | 9.967M |
| December 31, 2020 | 14.39M |
| September 30, 2020 | 7.806M |
| December 31, 2019 | 140.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.813M
Minimum
Jun 2021
140.37M
Maximum
Dec 2019
28.98M
Average
23.76M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 681.22M |
| Shareholders Equity (Quarterly) | 656.22M |